Health Care & Life Sciences » Biotechnology | ReNeuron Group PLC

ReNeuron Group PLC

ReNeuron Group PLC
Stock Exchange London Stock Exchange
EPS
GBP42.25
Market Cap
GBP73.15 M
Shares Outstanding
31.8 M
Public Float
30.53 M

Profile

Address
Pencoed Business Park
Pencoed BJ CF35 5HY
United Kingdom
Employees -
Website http://reneuron.com
Updated 07/08/2019
ReNeuron Group Plc engages in the development of novel cell based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom.

Financials

View All
Created with Highcharts 5.0.14ReNeuron Group PLCNet Income. Fiscal year is April-March. All values GBP Thousands.7 0667 0668 9068 90611 35411 35415 57315 57317 61517 6152014201520162017201805k10k15k20k
Created with Highcharts 5.0.14ReNeuron Group PLCSales/Revenue. Fiscal year is April-March. All values GBP Thousands.222230302929464643432014201520162017201801020304050

Olav Hellebø
Chief Executive Officer & Executive Director
Michael Elliot Hunt
CFO, Secretary & Executive Director